Literature DB >> 33514941

Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation.

Saeed R Khan1, Benjamin K Canales2, Paul R Dominguez-Gutierrez2.   

Abstract

Idiopathic calcium oxalate (CaOx) stones often develop attached to Randall's plaque present on kidney papillary surfaces. Similar to the plaques formed during vascular calcification, Randall's plaques consist of calcium phosphate crystals mixed with an organic matrix that is rich in proteins, such as inter-α-trypsin inhibitor, as well as lipids, and includes membrane-bound vesicles or exosomes, collagen fibres and other components of the extracellular matrix. Kidney tissue surrounding Randall's plaques is associated with the presence of classically activated, pro-inflammatory macrophages (also termed M1) and downregulation of alternatively activated, anti-inflammatory macrophages (also termed M2). In animal models, crystal deposition in the kidneys has been associated with the production of reactive oxygen species, inflammasome activation and increased expression of molecules implicated in the inflammatory cascade, including osteopontin, matrix Gla protein and fetuin A (also known as α2-HS-glycoprotein). Many of these molecules, including osteopontin and matrix Gla protein, are well known inhibitors of vascular calcification. We propose that conditions of urine supersaturation promote kidney damage by inducing the production of reactive oxygen species and oxidative stress, and that the ensuing inflammatory immune response promotes Randall's plaque initiation and calcium stone formation.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33514941     DOI: 10.1038/s41581-020-00392-1

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  182 in total

Review 1.  Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease.

Authors:  H G Tiselius
Journal:  BJU Int       Date:  2001-07       Impact factor: 5.588

Review 2.  Epidemiology of stone disease across the world.

Authors:  Igor Sorokin; Charalampos Mamoulakis; Katsuhito Miyazawa; Allen Rodgers; Jamsheer Talati; Yair Lotan
Journal:  World J Urol       Date:  2017-02-17       Impact factor: 4.226

3.  Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study.

Authors:  P Strazzullo; G Barba; P Vuotto; E Farinaro; A Siani; V Nunziata; F Galletti; M Mancini; F P Cappuccio
Journal:  Nephrol Dial Transplant       Date:  2001-11       Impact factor: 5.992

4.  Risk of chronic and end stage kidney disease in patients with nephrolithiasis.

Authors:  Jonathan Shoag; Joshua Halpern; David S Goldfarb; Brian H Eisner
Journal:  J Urol       Date:  2014-06-11       Impact factor: 7.450

5.  Prevalence of kidney stones in the United States.

Authors:  Charles D Scales; Alexandria C Smith; Janet M Hanley; Christopher S Saigal
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

Review 6.  The association of nephrolithiasis with hypertension and obesity: a review.

Authors:  Sergio H Obligado; David S Goldfarb
Journal:  Am J Hypertens       Date:  2008-01-24       Impact factor: 2.689

7.  Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994.

Authors:  Bradford West; Amy Luke; Ramon A Durazo-Arvizu; Guichan Cao; David Shoham; Holly Kramer
Journal:  Am J Kidney Dis       Date:  2008-03-20       Impact factor: 8.860

Review 8.  Nephrolithiasis and loss of kidney function.

Authors:  Mira T Keddis; Andrew D Rule
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-07       Impact factor: 2.894

9.  Diabetes and nephrolithiasis.

Authors:  Michel Daudon; Paul Jungers
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

10.  Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study.

Authors:  Guifeng Xu; Buyun Liu; Yangbo Sun; Yang Du; Linda G Snetselaar; Frank B Hu; Wei Bao
Journal:  BMJ       Date:  2018-09-04
View more
  26 in total

1.  Enterobacter cloacae: a villain in CaOx stone disease?

Authors:  Yuanyuan Yang; Senyuan Hong; Jinzhou Xu; Cong Li; Shaogang Wang; Yang Xun
Journal:  Urolithiasis       Date:  2022-02-06       Impact factor: 3.436

2.  Renal Macrophages and Multinucleated Giant Cells: Ferrymen of the River Styx?

Authors:  Mayandi Sivaguru; Bruce W Fouke
Journal:  Kidney360       Date:  2022-07-22

Review 3.  Mechanisms of the intestinal and urinary microbiome in kidney stone disease.

Authors:  Aaron W Miller; Kristina L Penniston; Kate Fitzpatrick; José Agudelo; Gregory Tasian; Dirk Lange
Journal:  Nat Rev Urol       Date:  2022-09-20       Impact factor: 16.430

4.  Analysis and Characterization of Lactobacillus paragasseri and Lacticaseibacillus paracasei: Two Probiotic Bacteria that Can Degrade Intestinal Oxalate in Hyperoxaluric Rats.

Authors:  Yogita Mehra; Nachiappa Ganesh Rajesh; Pragasam Viswanathan
Journal:  Probiotics Antimicrob Proteins       Date:  2022-06-14       Impact factor: 5.265

5.  Collagen fibrils and cell nuclei are entrapped within Randall's plaques but not in CaOx matrix overgrowth: A microscopic inquiry into Randall's plaque stone pathogenesis.

Authors:  Victor Hugo Canela; Sharon B Bledsoe; Elaine M Worcester; James E Lingeman; Tarek M El-Achkar; James C Williams
Journal:  Anat Rec (Hoboken)       Date:  2021-11-30       Impact factor: 2.227

Review 6.  Human kidney stones: a natural record of universal biomineralization.

Authors:  Mayandi Sivaguru; Jessica J Saw; Elena M Wilson; John C Lieske; Amy E Krambeck; James C Williams; Michael F Romero; Kyle W Fouke; Matthew W Curtis; Jamie L Kear-Scott; Nicholas Chia; Bruce W Fouke
Journal:  Nat Rev Urol       Date:  2021-05-24       Impact factor: 14.432

7.  Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.

Authors:  Kazumi Taguchi; Atsushi Okada; Rei Unno; Shuzo Hamamoto; Takahiro Yasui
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

8.  α-Klotho released from HK-2 cells inhibits osteogenic differentiation of renal interstitial fibroblasts by inactivating the Wnt-β-catenin pathway.

Authors:  Zewu Zhu; Shuhao Ruan; Yingcheng Jiang; Fang Huang; Weiping Xia; Jinbo Chen; Yu Cui; Cheng He; Feng Zeng; Yang Li; Zhiyong Chen; Hequn Chen
Journal:  Cell Mol Life Sci       Date:  2021-11-01       Impact factor: 9.261

9.  Polycyclic Aromatic Hydrocarbons and the Risk of Kidney Stones in US Adults: An Exposure-Response Analysis of NHANES 2007-2012.

Authors:  Si Sun; Weipu Mao; Shuchun Tao; Xiangyu Zou; Shengwei Tian; Siwei Qian; Chi Yao; Guangyuan Zhang; Ming Chen
Journal:  Int J Gen Med       Date:  2021-06-21

Review 10.  Recent advances on the mechanisms of kidney stone formation (Review).

Authors:  Zhu Wang; Ying Zhang; Jianwen Zhang; Qiong Deng; Hui Liang
Journal:  Int J Mol Med       Date:  2021-06-16       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.